Disease / condition
HIV Infection clinical trials
Free access to 335 studies10+ countriesUpdated daily14 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
335
Total trials
10+
Countries
10+
Sponsors
14
Recruiting
By phase
N/A149
Phase 344
Phase 142
Phase 441
Phase 239
By status
Completed253
Unknown24
Terminated20
Recruiting14
Not yet recruit...9
Top countries
United States of America111
Spain19
France17
Italy13
Canada11
Top sponsors
National Institute...23
University of Nort...20
GlaxoSmithKline14
ANRS, Emerging Inf...13
National Cancer In...9
Recent trials
Latest clinical trials for HIV Infection
UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children
PENTA Foundation
NCT05993767Not yet recr...
- Phase
- Phase 2
A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children
Fondazione Penta Onlus
2020-001426-57Ongoing
A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)
Merck Sharp & Dohme LLC · Australia,Canada,Israel,Japan,Puerto Rico,Russian Federation,Taiwan,United States of America
NCT05766501Recruiting
- Phase
- Phase 3
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
Icahn School of Medicine at Mo... · United States of America
NCT05652088Not yet recr...
A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals
IrsiCaixa · Spain
NCT05208125Active, not ...
- Phase
- Phase 1
Pathogen Detection in HIV-infected Children With Non-malarial Febrile Illnesses Using Metagenomic Sequencing
Makerere University
NCT05085158Not yet recr...
Traditional Healer-initiated HIV Counseling and Testing in South Africa
Vanderbilt University Medical ...
NCT05079347Not yet recr...
Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children
Raincy Montfermeil Hospital Gr... · France
NCT05085717Recruiting
Enhanced Adherence Counselling, Pre-Post Study
Elizabeth Glaser Pediatric AID... · Kenya
NCT04915469Completed
A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in South Korea
Yonsei University · South Korea
NCT04914130Not yet recr...
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study
HIV Vaccine Trials Network · Botswana,Malawi,South Africa,Zimbabwe
NCT04860323Recruiting
Antiretroviral Speed Access Program
Dr. Bertrand Lebouche · Canada
NCT04897243Recruiting
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
International Maternal Pediatr... · Botswana,Brazil,Haiti,Kenya,Malawi,South Africa,Tanzania,Thailand,Uganda,United States of America,Zi
NCT05154513Recruiting
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
HIV Vaccine Trials Network · Brazil,Peru,United States of America
NCT04801758Recruiting
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
National Institute of Allergy ... · United States of America
NCT04340596Recruiting
- Phase
- Phase 1
Triple vs. Double Therapy in naïves HIV-Infected Patients
Hospitales Universitarios Virg... · Spain
NCT04295460Recruiting
- Phase
- Phase 4
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial
Fred Hutchinson Cancer Researc... · Brazil,Peru
NCT04265950Recruiting
- Phase
- Phase 4
Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017))
Merck Sharp & Dohme Corp. · Australia,Canada,Chile,Colombia,France,Italy,Japan,New Zealand,Poland,Russian Federation,South Afric
NCT04223778Not yet recr...
- Phase
- Phase 3
Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)
Merck Sharp & Dohme Corp. · Australia,Austria,Canada,Finland,France,Germany,Italy,Japan,Puerto Rico,Spain,United States of Ameri
NCT04223791Not yet recr...
- Phase
- Phase 3
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation
IrsiCaixa · Italy,Netherlands,Spain
NCT04720742Suspended
- Phase
- Phase 2
About this profile
Access comprehensive clinical trial information for HIV Infection through Pure Global AI's free database. This collection includes 335 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 14 trials are actively recruiting participants.
Research for HIV Infection is being conducted in United States of America, Spain, France and 7+ other countries. Leading sponsors include National Institute of Allergy and Infectious Diseases (NIAID) and University of North Carolina, Chapel Hill. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 335 clinical trials studying HIV Infection, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina, Chapel Hill, GlaxoSmithKline, among others.